Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments

Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments

Non-alcoholic steatohepatitis (NASH) develops from non-alcoholic fatty liver disease (NAFLD). Currently, around 25% of the population is estimated to have NAFLD, and 25% of NAFLD patients are estimated to have NASH. NASH is typically characterized by liver steatosis inflammation, and fibrosis driven...

Full description

Bibliographic Details
Main Authors:	Cheng Peng, Alastair G. Stewart, Owen L. Woodman, Rebecca H. Ritchie, Cheng Xue Qin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Series:	Frontiers in Pharmacology
Subjects:	animal models pharmacological treatments metabolic syndrome obesity non-alcoholic fatty liver disease non-alcoholic steatohepatitis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2020.603926/full

Similar Items

Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: A ten-year retrospective study
by: Ji Xiong, et al.
Published: (2015-08-01)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
by: Singh Deepak, et al.
Published: (2010-07-01)

Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
by: Bo Zhu, et al.
Published: (2021-09-01)

Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
by: Akinobu Takaki, et al.
Published: (2014-04-01)

Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
by: Maryam Mahjoubin-Tehran, et al.
Published: (2021-08-01)

A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy
by: Kyoungbun Lee, et al.
Published: (2020-05-01)

Presence and Implications of Sarcopenia in Non-Alcoholic Steatohepatitis
by: Gregory Habig, et al.
Published: (2021-04-01)

Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature review
by: Yuichiro Eguchi, et al.
Published: (2020-10-01)

Сomparative Study of Progepar Efficacy in Patients with Non-Alcoholic Steatohepatitis
by: V.G. Perederii, et al.
Published: (2015-11-01)

Steatohepatitis in Children with Obesity
by: Alexander A. Zvyagin, et al.
Published: (2021-05-01)

The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH)
by: Hannah K. Drescher, et al.
Published: (2019-06-01)

Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role
by: Stefania De Lorenzo, et al.
Published: (2020-10-01)

Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease
by: Georgios Kranidiotis, et al.
Published: (2013-05-01)

FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
by: Erik J. Tillman, et al.
Published: (2020-12-01)

Rapid Recovery from Acute Liver Failure Secondary to Pancreatoduodenectomy-Related Non-Alcoholic Steatohepatitis
by: Kazushige Nirei, et al.
Published: (2013-01-01)

Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients
by: Rubén Díez-Rodríguez, et al.
Published: (2014-12-01)

Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial
by: Shahinul Alam, et al.
Published: (2016-01-01)

Structure of anaemic conditions comorbid to alcoholic and non-alcoholic steatohepatitis
by: Oksana Khukhlina, et al.
Published: (2021-05-01)

Morphological basis for the assessment of steatosis, steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease associated with obesity and pathology of the biliary tract
by: Yu.M. Stepanov, et al.
Published: (2017-09-01)

Geniposide and Chlorogenic Acid Combination Ameliorates Non-alcoholic Steatohepatitis Involving the Protection on the Gut Barrier Function in Mouse Induced by High-Fat Diet
by: Jing-hua Peng, et al.
Published: (2018-12-01)

Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
by: Ahn, S.H, et al.
Published: (2022)

Primary care practitioners survey of non-alcoholic fatty liver disease
by: Adnan Said, et al.
Published: (2013-09-01)

Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?
by: Masatoshi Kudo
Published: (2021-07-01)

REVIEW PAPER<br>Non-alcoholic steatohepatitis (NASH)
by: János Fehér, et al.
Published: (2005-04-01)

Non Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure
by: Alabagi Abdulla, et al.
Published: (2016-04-01)

Inadequate identification of fatty liver disease, obesity, and metabolic syndrome by family physicians
by: Mahamid M, et al.
Published: (2018-09-01)

Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
by: Clarissa Berardo, et al.
Published: (2020-12-01)

Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis – Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue
by: Samuel J. Daniels, et al.
Published: (2019-03-01)

Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
by: Hyeok-Hee Lee, et al.
Published: (2020-06-01)

The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients
by: Narges Ashraf Ganjooei, et al.
Published: (2021-05-01)

The Neutrophil-to-Lymphocyte Ratio as A Noninvasive Marker in Patients with Biopsy-Proven Non-Alcoholic Steatohepatitis
by: Mehmet Asıl, et al.
Published: (2016-12-01)

Gut Dysbiosis and Increased Intestinal Permeability Drive microRNAs, NLRP-3 Inflammasome and Liver Fibrosis in a Nutritional Model of Non-Alcoholic Steatohepatitis in Adult Male Sprague Dawley Rats
by: Longo L, et al.
Published: (2020-09-01)

Evaluating causality of cellular senescence in non-alcoholic fatty liver diseaseKey points
by: Abraham Stijn Meijnikman, et al.
Published: (2021-08-01)

The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights
by: Alessandro Federico, et al.
Published: (2021-04-01)

Changes in direct markers of liver fibrosis in patients with steatohepatitis non-alcoholic and alcoholic origin on the background of obesity and pathology of the biliary tract
by: A. Yu. Filippova
Published: (2017-04-01)

Gut Dysbiosis and Increased Intestinal Permeability Drive microRNAs, NLRP-3 Inflammasome and Liver Fibrosis in a Nutritional Model of Non-Alcoholic Steatohepatitis in Adult Male Sprague Dawley Rats [Erratum]
by: Longo L, et al.
Published: (2020-10-01)

Signaling in Simple Steatosis and Non-alcoholic Steatohepatitis Cirrhosis: TGF-β1, YAP/TAZ, and Hedgehog Pathway Activity
by: Sina Mohagheghi, et al.
Published: (2018-12-01)

Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis
by: Atsuko Takai, et al.
Published: (2020-02-01)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
by: Helma P. Cotrim, et al.
Published: (2016-05-01)

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
by: Oriol Juanola, et al.
Published: (2021-05-01)